Literature DB >> 25288604

The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π.

Laurence H Beck1.   

Abstract

Entities:  

Keywords:  PLA2R; autoimmune; membranous nephropathy

Mesh：

Substances：

Year:  2014        PMID： 25288604      PMCID： PMC4310670          DOI： 10.1681/ASN.2014090877

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  14 in total

Review 1.  Extended and bent conformations of the mannose receptor family.

Authors:  O Llorca
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

2.  Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.

Authors:  Marieke J H Coenen; Julia M Hofstra; Hanna Debiec; Horia C Stanescu; Alan J Medlar; Bénédicte Stengel; Anne Boland-Augé; Johanne M Groothuismink; Detlef Bockenhauer; Steve H Powis; Peter W Mathieson; Paul E Brenchley; Robert Kleta; Jack F M Wetzels; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

3.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

4.  Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.

Authors:  Sejoong Kim; Ho Jun Chin; Ki Young Na; Suhnggwon Kim; Jieun Oh; Wookyung Chung; Jung Woo Noh; Young Ki Lee; Jong Tae Cho; Eun Kyoung Lee; Dong-Wan Chae
Journal:  Nephron Clin Pract       Date:  2010-08-31

5.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Authors:  Elion Hoxha; Ursula Kneißler; Gesa Stege; Gunther Zahner; Ina Thiele; Ulf Panzer; Sigrid Harendza; Udo M Helmchen; Rolf A K Stahl
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

6.  Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.

Authors:  Yu-Huei Liu; Cheng-Hsu Chen; Shih-Yin Chen; Ying-Ju Lin; Wen-Ling Liao; Chang-Hai Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-10-11       Impact factor: 8.410

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.

Authors:  Liyo Kao; Vinson Lam; Meryl Waldman; Richard J Glassock; Quansheng Zhu
Journal:  J Am Soc Nephrol       Date:  2014-09-09       Impact factor: 10.121

9.  Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.

Authors:  Maryline Fresquet; Thomas A Jowitt; Jennet Gummadova; Richard Collins; Ronan O'Cualain; Edward A McKenzie; Rachel Lennon; Paul E Brenchley
Journal:  J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 10.121

10.  An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.

Authors:  Astrid Behnert; Marvin J Fritzler; Beina Teng; Meifeng Zhang; Frank Bollig; Hermann Haller; Andrej Skoberne; Michael Mahler; Mario Schiffer
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240
View more
  6 in total

1.  MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.

Authors:  Zhao Cui; Li-Jun Xie; Fang-Jin Chen; Zhi-Yong Pei; Li-Jie Zhang; Zhen Qu; Jing Huang; Qiu-Hua Gu; Yi-Miao Zhang; Xin Wang; Fang Wang; Li-Qiang Meng; Gang Liu; Xu-Jie Zhou; Li Zhu; Ji-Cheng Lv; Fan Liu; Hong Zhang; Yun-Hua Liao; Lu-Hua Lai; Pierre Ronco; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2016-11-16       Impact factor: 10.121

Review 2.  Blocking peptides and molecular mimicry as treatment for kidney disease.

Authors:  Andrea Havasi; Weining Lu; Herbert T Cohen; Laurence Beck; Zhiyong Wang; Chinaemare Igwebuike; Steven C Borkan
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-21

3.  Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Guillaume Dolla; Christine Payré; Christophe A Girard; Joel Polidori; Kevin Zorzi; Eléonore Birgy-Barelli; Perrine Jullien; Cécile Courivaud; Thierry Krummel; Sylvia Benzaken; Ghislaine Bernard; Stéphane Burtey; Christophe Mariat; Vincent L M Esnault; Gérard Lambeau
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 4.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

Review 5.  Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.

Authors:  Bogdan Obrisca; Gener Ismail; Roxana Jurubita; Catalin Baston; Andreea Andronesi; Gabriel Mircescu
Journal:  Biomed Res Int       Date:  2015-10-20       Impact factor: 3.411

Review 6.  Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.

Authors:  Andreas Kronbichler; Jun Oh; Björn Meijers; Gert Mayer; Jae Il Shin
Journal:  Biomed Res Int       Date:  2017-08-17       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.